Inter Pharma Public Company Limited

Total Valuation

Inter Pharma Public Company Limited carries a market capitalization of 2.74B, placing it among publicly traded companies globally. Its enterprise value stands at 2.76B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Inter Pharma Public Company Limited currently has 605.34M shares outstanding.

Valuation Ratios

Inter Pharma Public Company Limited trades at a trailing price-to-earnings ratio of 18.38. The price-to-sales ratio is 1.10, and the price-to-book ratio stands at 4.33.

Enterprise Valuation

On an enterprise value basis, Inter Pharma Public Company Limited trades at an EV/EBITDA multiple of 8.43 and an EV/FCF ratio of 6.35. The EV/Sales ratio of 1.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.25 provides insight into valuation relative to core operating earnings.

Financial Position

Inter Pharma Public Company Limited maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.12, indicating elevated leverage, while an interest coverage ratio of 17.59 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Inter Pharma Public Company Limited posts a return on equity of 26.57 and a return on invested capital of 6.08.

Taxes

Over the trailing twelve months, Inter Pharma Public Company Limited has paid 40.45M in income taxes, reflecting an effective tax rate of 21.46.

Stock Price Statistics

Inter Pharma Public Company Limited's stock has gained approximately 35.32934% over the past 52 weeks. The 50-day moving average sits at 4.28, while the 200-day moving average is 4.19.

Income Statement

Over the trailing twelve months, Inter Pharma Public Company Limited generated 2.22B in revenue and converted that into 133.05M in net income, yielding earnings per share of 0.24. EBITDA reached 327.71M, while operating income came in at 208.34M.

Balance Sheet

Inter Pharma Public Company Limited holds 305.01M in cash and equivalents against 376.99M in total debt, resulting in a net debt position of -11.11M. Total book value stands at 565.05M, with working capital of 515.44M providing operational flexibility.

Cash Flow

Inter Pharma Public Company Limited produced 277.25M in operating cash flow over the past twelve months. After subtracting -142.58M in capital expenditures, free cash flow totaled 134.67M - equivalent to 0.22 per share.

Margins

Inter Pharma Public Company Limited operates with a gross margin of 41.79, reflecting its pricing power and cost economics. The operating margin of 9.37 and net profit margin of 5.99 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Inter Pharma Public Company Limited's most recent stock split took place on May 7, 2024 with a 8:13 split ratio.

Scores

Inter Pharma Public Company Limited posts an Altman Z-Score of 3.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.